(Q62664175)
Statements
Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies (English)
David Olmos
Nina Tunariu
Ruth Riisnaes
Lorna Pope
Jeremy Clark
David Collins
Carol Waghorne
Feng Chai
Edward Garmey
Timothy A Yap
Andre T Brunetto
Nandita M deSouza
Ronald E Savage
Stan B Kaye
Johann S de Bono